Myricx Bio is a Biotech company based in London, UK. It has raised $114M in total funding. Latest round: Series A.
Myricx Bio is a Biotech company based in London, UK. Myricx Bio has raised $114M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Myricx Bio runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, Abingworth, Brandon Capital, Sofinnova Partners, British Patient Capital, Cancer Research Horizons and 1 others. 7 distinct backers are named across the disclosed rounds.
We update the Myricx Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in London and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026